Navigation Links
Inflammatory Substance May Boost Eye Trouble

C-reactive protein raises odds of age-related macular degeneration, experts say

MONDAY, Oct. 8 (HealthDay News) -- People with high blood levels of C-reactive protein, a substance associated with inflammation, may be at higher risk of developing age-related macular degeneration (AMD), a major cause of vision loss in older adults.

Dutch researchers collected blood samples and took photographs of the eyes of more than 4,900 people at risk for AMD. They then followed the group for an average of 7.7 years.

During that time, 658 of the participants were diagnosed with AMD -- 561 with initial stage AMD and 97 with advanced AMD.

As an individual's C-reactive protein level increased above the midpoint of the study group, the person became more and more likely to develop AMD, the researchers found.

The study is published in the October issue of the journal Archives of Ophthalmology.

The findings suggest that lowering C-reactive protein levels may help decrease AMD risk, the study authors said.

"A substance that can selectively inhibit C-reactive protein synthesis has not yet been developed, to our knowledge," wrote a team from Erasmus Medical Center, Rotterdam. "Smoking and high body mass index increase C-reactive protein levels. Moderate alcohol intake, diets with a low glycemic index and statin [drugs] and multivitamin use reduce C-reactive protein levels."

It's known that smoking and obesity increase the risk of AMD, which occurs when the macula -- the area at the back of the retina involved in sharp vision -- deteriorates over time.

More information

The U.S. National Eye Institute has more about AMD.

-- Robert Preidt

SOURCE: JAMA/Archives journals, news release, Oct. 8, 2007

Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Inflammatory bowel disease linked to genetic abnormality
2. Safeguarding anti-inflammatory users from ulcers
3. Gel pares inflammatory activity throughout body
4. The Usage Of Anti-Inflammatory Drugs Questioned
5. Hope For Patients With Inflammatory Bowel Disease
6. FDA to bring about changes in Marketed Non-Steroidal Anti-Inflammatory Drugs
7. Anti-inflammatory drugs reduce the risk of oral cancer for smokers
8. Elevated Insulin Levels To Influence Levels Of Inflammatory Markers
9. Cannabinoids drug for inflammatory bowel
10. Cannabinoids - Antidepressant And Inflammatory Bowel Disease Treatment
11. Ambiguous Efficacy Of Opioid Drugs In Chronic Inflammatory Joint Pain Relief
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... ... authorized OSHA Training Institute Education Center headquartered in Northern California, has issued an ... extreme heat at their worksites. Employers with workers exposed to high temperatures ...
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media with ... X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color ... users can now reveal the media of their split screens with growing colorful ...
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, ... its affiliation with Tennessee Counseling Association. This new relationship allows TherapySites ... Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA is extremely ...
(Date:6/27/2016)... California (PRWEB) , ... June ... ... pioneer in the patient payment industry today announced its strategic partnership with ... health system workflows. , The two companies’ proven, proprietary technology combine to ...
(Date:6/27/2016)... ... June 27, 2016 , ... A ... revolutionize the emergency ambulance transport experience for the millions of people who require ... has disrupted the taxi industry through the use of technology. Now, SmartEMS has ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... their offering. The current ... environment for MedImmune to enter. The US ageing population creates ... drive considerable growth for effective anti-influenza medications. The introduction of ... but development is still in its infancy. ...
Breaking Medicine Technology: